Email Updates
Commentary
Strengthening the use of artificial intelligence within healthcare delivery organizations: balancing regulatory compliance and patient safety.
June 5, 2024
Sendak MP, Liu VX, Beecy A, et al. J Am Med Inform Assoc. 2024;31(7):1622–1627.
In 2022, the Food and Drug Administration (FDA) released new guidance which impacts how artificial intelligence-based clinical decision support (CDS) tools are reviewed and approved. This article explores the impact of these changes on CDS tools for sepsis care and how healthcare organizations can ensure safe, equitable use of CDS tools.
Related Resources From the Same Author(s)
Related Resources
Patient Safety Innovations
Remote Response Team and Customized Alert Settings Help Improve Management of Sepsis
See More About The Topic
